Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215234) titled 'A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Sanofi
Condition:
Geographic Atrophy
Intervention:
Drug: SAR446597
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: October 15, 2025
Target Sample Size: 104
Countries of Recruitment:
United State...